HPTN 083: Injectable PrEP can make breakthrough infections hard to detect
Reformulated islatravir implant should provide PrEP for over a year
Large numbers now on Descovy PrEP in the United States
Better access to PrEP in the UK, especially through NHS services
Younger age, problems obtaining PrEP, and worries about side effects among the factors associated with PrEP discontinuation in Germany
High rates of starting and staying on PrEP in pregnant South African women, despite barriers
Antibiotics to prevent STIs – for or against?
African studies explore reasons to start, stick with or stop PrEP
Products to prevent both pregnancy and HIV begin to emerge
